Xu Z, Armstrong B K, Blundson B J, Rogers J M, Musk A W, Shilkin K B
Med J Aust. 1985 Sep 2;143(5):185-7.
Annual mortality from malignant mesothelioma of the pleura (MMP) in Australia (as represented by ICD8 codes 163.0 and 212.4, and ICD9 codes 163 and 212.4) increased in men aged 30 years and older from about 0.5/100 000 in 1968-1970 to 2.1/100 000 in 1983. Corresponding rates in women varied from 0.1/100 000 to 0.2/100 000 between 1968 and 1980, then rose to 0.3/100 000 in 1983. The rise in MMP mortality in men probably corresponds to the increasing use of asbestos, particularly amosite, in Australia during and after World War II. That production and importation of amosite and crocidolite in Australia reached a peak in 1958 may mean that peak mortality from MMP will not be reached until the 1990s (allowing a 35-year lag period). Substantial increases in importation and later production, of chrysotile in the 1950s, 1960s and 1970s may lead to increases in the incidence of other asbestos-related cancers, not reflected in trends in the incidence of MMP.
在澳大利亚,胸膜恶性间皮瘤(MMP)的年死亡率(以ICD8编码163.0和212.4以及ICD9编码163和212.4表示)在30岁及以上男性中从1968 - 1970年的约0.5/10万增加到1983年的2.1/10万。1968年至1980年间,女性的相应死亡率在0.1/10万至0.2/10万之间,然后在1983年升至0.3/10万。男性MMP死亡率的上升可能与澳大利亚在第二次世界大战期间及之后石棉,尤其是铁石棉的使用增加有关。澳大利亚铁石棉和青石棉的生产和进口在1958年达到峰值,这可能意味着直到20世纪90年代才会达到MMP的最高死亡率(考虑到35年的滞后时间)。20世纪50年代、60年代和70年代温石棉进口及随后产量的大幅增加可能会导致其他石棉相关癌症的发病率上升,而MMP发病率趋势并未反映这一点。